Ovarian NeoplasmsIncidenceNeoplasmsNeoplasms, Glandular and EpithelialRegistriesBreast NeoplasmsRisk FactorsCA-125 AntigenEarly Detection of CancerCystadenocarcinoma, SerousSEER ProgramCohort StudiesGenes, BRCA1Prostatic NeoplasmsUnited StatesLung NeoplasmsCell Line, TumorRiskProspective StudiesCarcinomaFollow-Up StudiesAge DistributionSurvival RateGene Expression Regulation, NeoplasticNeoplasm StagingRetrospective StudiesPrognosisAge FactorsStomach NeoplasmsNeoplasms, Radiation-InducedNeoplasm InvasivenessTumor Markers, BiologicalRisk AssessmentSurvival AnalysisAntineoplastic AgentsGenes, BRCA2Uterine Cervical NeoplasmsDrug Resistance, NeoplasmGenetic Predisposition to DiseaseMice, NudeSwedenColorectal NeoplasmsBRCA2 ProteinTime FactorsColonic NeoplasmsCisplatinPaclitaxelAdenocarcinoma, Clear CellBRCA1 ProteinPoisson DistributionIowaOccupational DiseasesEuropean Continental Ancestry GroupNeoplasm ProteinsOccupational ExposureSmokingCarcinoma, EndometrioidJapanOdds RatioEndometrial NeoplasmsConfidence IntervalsSex DistributionPeritoneal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsNeoplasm MetastasisCase-Control StudiesAdenocarcinoma, MucinousMutationAscitesDisease ProgressionMass ScreeningXenograft Model Antitumor AssaysMammographyAdenocarcinomaGerm-Line MutationReverse Transcriptase Polymerase Chain ReactionDenmarkProportional Hazards ModelsTreatment OutcomePancreatic NeoplasmsAlaskaMultivariate AnalysisCaliforniaCell ProliferationGenital Neoplasms, Female